World's first jab to stop skin cancer being tested in UK patients
- A personalized mRNA cancer jab is being tested in British patients for melanoma, with potential to target bladder, lung, and kidney cancer.
- In a trial, the jab reduced the risk of cancer recurrence in melanoma patients, leading to a final trial launch.
- The therapy involves DNA sequencing of a tumor sample and artificial intelligence, showing promising results for high-risk melanoma patients.
Insights by Ground AI
Does this summary seem wrong?
0 Articles
0 Articles
All
Left
Center
Right
Coverage Details
Total News Sources0
Leaning Left4Leaning Right2Center5Last Updated10 days agoBias Distribution45% Center
Bias Distribution
- 45% of the sources are Center
46% Center
L 36%
C 46%
R 18%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage